Privia Health Group, Inc. (PRVA) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wal
Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago.
All 2025 Operating and Financial Metrics At or Above High End of Guidance Ranges Full-year 2025 Net Income +59.3% from 2024 Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024 Full-year
Evaluate the expected performance of Privia Health (PRVA) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key m
Privia Health Group (NASDAQ: PRVA - Get Free Report) is anticipated to issue its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of
Privia Health Group (NASDAQ: PRVA - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on
Butterfly Network (NYSE: BFLY - Get Free Report) and Privia Health Group (NASDAQ: PRVA - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two busin
Pulmonx (NASDAQ: LUNG - Get Free Report) and Privia Health Group (NASDAQ: PRVA - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses base
Privia Health Group (NASDAQ: PRVA - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both mid-cap medical companies, but which is the better investment? We will contrast th
ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods
Three Healthcare IT stocks have surged over 20% in 2025, driven by growth in telehealth, remote monitoring and value-based care platforms.
Privia Health Group (NASDAQ: PRVA - Get Free Report) and Decision Diagnostics (OTCMKTS:DECN - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two
Privia Health Group, Inc. (NASDAQ: PRVA - Get Free Report) CFO David Mountcastle sold 23,887 shares of the firm's stock in a transaction that occurred on Friday, December 12th. The shares were sold at
Precipio (NASDAQ: PRPO - Get Free Report) and Privia Health Group (NASDAQ: PRVA - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE